International Patent: A THERAPEUTIC VHH ANTIBODY THAT BLOCKS INFECTION BY HERPES SIMPLEX VIRUSES 1 AND 2

GENEVA, Aug. 31 -- MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. filed a patent application (EP2026/054668) for “A THERAPEUTIC VHH ANTIBODY THAT BLOCKS INFECTION BY HERPES SIMPLEX VIRUSES 1 AND 2”. With publication no. WO/2026/176042, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61P 31/22

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....